Original Research
Published on 09 May 2024
Engineered endolysin of Klebsiella pneumoniae phage is a potent and broad-spectrum bactericidal agent against “ESKAPEE” pathogens
in Antimicrobials, Resistance and Chemotherapy
- 475 views
Original Research
Published on 09 May 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 09 May 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 07 May 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 07 May 2024
in Antimicrobials, Resistance and Chemotherapy
Review
Published on 07 May 2024
in Antimicrobials, Resistance and Chemotherapy
Review
Accepted on 03 May 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 02 May 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 01 May 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Accepted on 30 Apr 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 30 Apr 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 30 Apr 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 30 Apr 2024
in Antimicrobials, Resistance and Chemotherapy
Review
Published on 29 Apr 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 29 Apr 2024
in Antimicrobials, Resistance and Chemotherapy
Original Research
Published on 29 Apr 2024
in Antimicrobials, Resistance and Chemotherapy
Systematic Review
Published on 29 Apr 2024
in Antimicrobials, Resistance and Chemotherapy